• Viewpoint
    May 13, 2026

    Private markets are under pressure to move faster and show stronger evidence of performance and control. Deal sourcing and screening now span thousands of fragmented sources. Limited Partners (LPs) want continuous, verifiable visibility into fund and…
  • Viewpoint
    May 01, 2023

    The COVID-19 outbreak compelled the life sciences industry to innovate and transform digitally. However, the current global macroeconomic and socio-political uncertainty, coupled with increasing research and development IT expenditure, have created immense pressure on the pharmaceutical…